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Introduction {#sec001}
============

The intestinal microbiome is one of the most important reservoirs of clinically relevant antimicrobial resistance (AMR) genes \[[@pone.0222831.ref001]\]. Accurate detection and quantification of AMR genes within an individual's gut microbiome (their gut 'resistome') could allow the impact of different types of antibiotic exposures to be evaluated and guide interventions to reduce AMR. This would be particularly helpful for antimicrobial stewardship, as current policies often categorise agents by their clinical spectrum alone, which may poorly reflect their actual impact on the gut microbiome and resistome \[[@pone.0222831.ref002]\]. Reliable quantification is an important feature of a resistome assay, as although simply classifying individuals as 'colonized' or 'not colonized' is useful in many settings, often the selection of resistance consists of increasing the abundance of organisms already present \[[@pone.0222831.ref003],[@pone.0222831.ref004]\]. In addition, the abundance of antimicrobial resistant organisms in the gut has been associated with risk of invasive infection and onward transmission \[[@pone.0222831.ref003],[@pone.0222831.ref005]\].

Unfortunately, all current methods of measuring the fecal resistome have major limitations. Quantitative culture requires further genotyping to define resistance elements and can only practically be used for a small number of species present in feces \[[@pone.0222831.ref006]\], and targeted molecular approaches, such as qPCR, cannot simultaneously detect the dozens of AMR genes and mutations that may be present in a sample from among thousands of known types \[[@pone.0222831.ref007],[@pone.0222831.ref008]\]. Because of these shortcomings, metagenomic sequencing performed directly from extracted fecal DNA is increasingly being used to characterise the gut resistome, as it produces millions of short DNA reads that can be matched to a catalogue of thousands of AMR genes, theoretically producing a representative, quantitative description of AMR genes in a sample \[[@pone.0222831.ref001],[@pone.0222831.ref007],[@pone.0222831.ref009]\].

However, a major limitation of direct sequencing is the inability to detect clinically important resistance genes present at low abundance \[[@pone.0222831.ref010]\]. In particular, the *Enterobacteriaceae*, which include major drug resistant human pathogens such as *Escherichia coli*, *Salmonella* and *Klebsiella* species, may be present in feces at levels too low for AMR gene detection by direct sequencing. In one recent study, metagenomic sequencing detected an extended spectrum beta-lactamase (ESBL) in just 12 of 26 (46%) culture positive stool samples, missing all 9 samples with an abundance of \<10^6^ CFU/g \[[@pone.0222831.ref011]\]. Increasing the depth of sequencing to detect scarce organisms seems appealing but is not currently feasible. For example, it would not be unusual for a resistant *E*. *coli* to be present at an abundance of 10^3^ cells/g in feces with a total organism count of 10^11^ cells/g \[[@pone.0222831.ref011],[@pone.0222831.ref012]\], so using short read sequencing to detect a 1kb AMR gene in this organism would require hundreds of billions of reads, costing many hundreds of thousands of dollars.

Here we assess whether a short period of selective culture enrichment of fecal samples before sequencing can improve the detection and quantification of AMR in *Enterobacteriaceae* by raising their abundance above the threshold of detection. We show that the methods tested can lower the limit of detection of selected resistance mechanisms, but that they are unable to provide reliable quantification, highlighting the difficulties of using these, or other similar approaches.

Materials and methods {#sec002}
=====================

Experiment 1---Comparison of DNA extraction methods {#sec003}
---------------------------------------------------

Preliminary experiments were performed to identify a DNA extraction protocol that would efficiently extract resistance genes present in *Enterobacteriaceae*. As acquired resistance genes in *Enterobacteriaceae* are typically present on plasmids, we hypothesised that a plasmid extraction protocol would increase detection of these genes. The QuickLyse Miniprep Kit (Qiagen), a spin column-based plasmid extraction kit, was compared to a standard fecal DNA extraction protocol, the QIAamp Fast DNA Stool Mini Kit (Qiagen) modified to include mechanical lysis with bead beating. One hundred milligram aliquots from two different volunteer fecal sample were spiked with one of two *Enterobacteriaceae* carrying plasmid-associated beta-lactamases (*K*. *pneumoniae* with NDM-1 and CTX-M-15, or *E*. *cloacae* with KPC-2 and TEM-1). Spike organisms were added at a concentration of 10^8^ CFU/g and negative controls with no spike were run in parallel. Following DNA extraction using the two methods, sequencing was performed on Illumina MiSeq with a mean sequencing depth of 1.4 million paired reads per sample.

Experiment 2 --Establishing the optimal duration of enrichment culture {#sec004}
----------------------------------------------------------------------

Before assessing a protocol of enrichment-culture and direct sequencing, we first had to determine the optimal duration of culture. We therefore performed an experiment in which 100mg of a fecal sample was incubated in Mueller-Hinton broth containing metronidazole (20mg/L) and vancomycin (20mg/L), repeated in duplicate. These antibiotics were added to suppress the growth of anaerobic and gram-positive organisms but allow growth of *Proteobacteria*, which would primarily consist of *Enterobacteriaceae*. Quantitative culture was performed after 0, 4, 6, 8, 10 and 24 hours incubation.

Experiment 3 --Sequencing after selective enrichment with vancomycin and metronidazole {#sec005}
--------------------------------------------------------------------------------------

We then assessed the effect of this selective enrichment protocol on sequencing-based detection of AMR genes present in *Enterobacteriaceae*. One hundred milligram aliquots from a single fecal sample were spiked with *E*. *coli* containing NDM-1 at concentrations of 0 -- 5x10^5^ CFU/g, repeated in triplicate. These had 6 hours of enrichment culture in broth containing metronidazole and vancomycin as above, followed by DNA extraction from the pelleted broth with the Fast DNA Stool kit and sequencing on Illumina MiSeq with a mean sequencing depth of 1.7 million paired reads per sample.

Experiment 4 --Sequencing after selective enrichment with vancomycin, metronidazole and cefpodoxime {#sec006}
---------------------------------------------------------------------------------------------------

A second culture-enrichment protocol was tested, which was the same as above apart from the addition of cefpodoxime (1mg/L) and use of the QuickLyse Miniprep Kit for DNA extraction. To establish the performance of this protocol, another spiking experiment was performed using fecal samples from two volunteers. One hundred milligram aliquots from the samples were spiked with one of two different carbapenemase-producing *Enterobacteriaceae* (CPE) (NDM-1 *K*. *pneumoniae* or KPC-2 *E*. *cloacae*) at spikes ranging from 0 -- 5x10^7^ CFU/g. Unenriched controls were run in parallel and all conditions were repeated in duplicate. In addition, to allow estimation of the number of CPE organisms in post-enrichment samples using sequencing data, a standard spike of 10^7^ CFU of *Staphylococcus aureus* was added to all samples except negative controls immediately prior to DNA extraction. Sequencing was performed on Illumina MiSeq to a mean depth of 1.4 million paired reads per sample. Quantitative culture was also performed on all samples.

Specimens {#sec007}
---------

The Antibiotic Resistance in the Microbiome Oxford (ARMORD) study gathers fecal samples from participants to study antimicrobial resistance. The study was approved by Leicester Research Ethics Committee (reference 15/EM/0270) and all participants provided informed consent. Stool samples from two ARMORD participants were used for experiments 1, 3 and 4. Participant A was a hospital inpatient with exposure to a third-generation cephalosporin antibiotic (ceftazidime) 48 hours previously, participant B was a healthy volunteer with no recent antibiotic exposure. Samples were frozen at -80°C within 2 hours of collection and were confirmed to be culture-negative for ESBL producing *Enterobacteriaceae* using overnight growth in Mueller Hinton broth containing 1mg/L cefpodoxime (Sigma-Aldrich) followed by inoculation onto ESBL Brilliance agar (Oxoid) for 24 hours at 37°C in aerobic conditions \[[@pone.0222831.ref013]\]. Experiment 2 used a discarded fecal sample from the clinical microbiology laboratory at the Oxford University Hospitals NHS Foundation Trust.

Quantitative culture {#sec008}
--------------------

Modified track plating was used to quantify *Enterobacteriaceae* in fecal samples \[[@pone.0222831.ref014]\]. Samples were serially diluted 10-fold in peptone water with pipette mixing at each step. Culture of 10μl from dilutions 1:10--1:10^8^ was performed on CHROMagar Orientation (BD) and ESBL Brilliance agar (Oxoid). Colonies were counted after incubation at 37°C for 16 hours in aerobic conditions.

Experimental bacterial strains {#sec009}
------------------------------

Three CPE strains were used for the spiking experiments described above, grown on CRE Brilliance agar (Fisher Scientific) at 37°C in aerobic conditions.

1.  *E*. *coli* H17. Contains NDM-1 beta-lactamase on unresolved plasmid, isolated from a hospital outbreak in Nepal (SAMN02885348) \[[@pone.0222831.ref015]\].

2.  *Klebsiella pneumoniae* PMK3. Contains NDM-1 and CTX-M-15 beta-lactamases on a 305kb plasmid, present at an estimated 1.8 copies per chromosome. Isolated from a hospital outbreak in Nepal (SAMN02885389) \[[@pone.0222831.ref015]\].

3.  *Enterobacter cloacae* CAV1668. Contains KPC-2 and TEM-1 beta-lactamases on a 43kb plasmid, present at an estimated 1.9 copies per chromosome. Isolated from a hospital outbreak in Virginia, USA (SAMN03733827) \[[@pone.0222831.ref016]\].

MRSA252 (SAMEA1705935) was used for the standard *S*. *aureus* spike, which was grown on blood agar (Fisher Scientific) at 37°C in aerobic conditions.

Spiking {#sec010}
-------

Overnight growth of bacteria was used to make a suspension of 5 MacFarland in nutrient broth with 10% glycerol (NBG) (Oxoid, BO1297G), measured using a BD PhoenixSpec nephelometer. Serial 10-fold dilutions were frozen at -80°C with culture from thawed aliquots used to define concentrations. Stool samples were vortexed with molecular water (Fisher Scientific) on ice at a ratio of 1:2 to create a pipettable suspension, 300mg of which was used per set of experimental conditions.

Enrichment {#sec011}
----------

Spiked samples were added to 20ml Mueller-Hinton broth (Sigma-Aldrich) containing 20mg/L vancomycin, 20mg/L metronidazole, and for experiment 4, 1mg/L cefpodoxime (all antibiotics Sigma-Aldrich). These were incubated at 37°C and shaken at 190rpm for 6 hours, then, for sequencing experiments, immediately centrifuged at 3200g for 10 min at 4°C to pellet bacteria. Supernatant was discarded and the pellet resuspended in 1ml molecular water.

DNA extraction {#sec012}
--------------

Two DNA extraction protocols were used.

1.  QuickLyse Miniprep Kit (Qiagen), used in experiments 1 and 4. Samples were centrifuged at 100g for 5 minutes to remove large particles, and DNA was then extracted from the supernatant according to the manufacturer's instructions. Briefly, bacterial cells were pelleted by centrifugation at 17,000g for 2 minutes and resuspended in 400μl ice-cold complete lysis solution by vortexing for 30s. After 3 minutes at room temperature the lysate was transferred to a QuickLyse spin column and centrifuged at 17,000g for 60s. The spin column was washed with 400μl QuickLyse wash buffer and centrifuged at 17,000g for 60s. After discarding the flow-through, the columns were dried by centrifuging at 17,000g for 60s. DNA was eluted from the spin column in 50 μl QuickLyse elution buffer by spinning at 17,000g for 60s.

2.  QIAamp Fast DNA Stool Mini Kit (Qiagen) plus mechanical lysis with bead beating, used in experiments 1 and 3. Samples were added to 1ml Stool Transport and Recovery buffer (Roche) in a 2ml Lysing Matrix E tube (MP Biomedicals), followed by bead beating for 2 x 40s with a FastPrep-24 5G instrument (MP Biomedicals) and incubation at 95°C for 5 minutes. Samples were then centrifuged at 1,000g for 60s. Supernatant was transferred to 1ml InhibitEX buffer, after which the manufacturer's instructions were followed for bacterial DNA extraction. Briefly, this involved mixing with 15μl proteinase K, 400μl AL lysis buffer and 400μl 100% ethanol. This was transferred to a QIAamp spin column and washed with 500μl AW1 and 500 μl AW2 buffers. DNA was then eluted in 50μl molecular water.

DNA library preparation and sequencing {#sec013}
--------------------------------------

Extracted DNA was purified using Ampure XP beads (Agilent). Fifty microliters of DNA was vortexed with 90μl Ampure XP beads and washed twice with 80% ethanol before elution in 25μl molecular water. DNA was normalized to 0.2ng/μl and libraries prepared from 1μg DNA using the Nextera XT Library preparation kit (Illumina) according to the manufacturer's instructions. Normalization and QC of libraries was performed using a Qubit 2.0 fluorometer (Thermo Fisher) and 2200 Tapestation (Agilent). Paired-end 300bp sequencing was performed on an Illumina MiSeq, with 10--16 samples multiplexed per sequencing run.

Bioinformatics {#sec014}
--------------

Human DNA reads (representing \<4% of sequences in all samples) were identified using the Kraken taxonomic classifier and removed prior to analysis \[[@pone.0222831.ref017]\]. Quality control metrics were assessed with FastQC \[[@pone.0222831.ref018]\], and BBduk was used to remove Illumina adapters and quality-trim reads using a phred-score cut-off of 10 \[[@pone.0222831.ref019]\]. MetaPhlAn2 was used for taxonomic classification \[[@pone.0222831.ref020]\], except for normalization to *S*. *aureus*, where Kraken was used to classify reads to the relevant species. BBMap was used to map reads to beta-lactamase genes, *gyrA* and plasmids using the relevant genes from assembled genomes specified in bacterial strains as the reference \[[@pone.0222831.ref019]\]. Plasmid copy number was estimated by mapping reads from sequenced isolates to a closely related closed reference genome using BWA-MEM \[[@pone.0222831.ref021]\]. For PMK3, the PMK1 reference was used (CP008929-CP008933), and for CAV1668, the CAV1668 reference was used (CP011582-CP011584). SAMtools was used to filter out supplementary alignments and calculate depth of coverage \[[@pone.0222831.ref022]\].

Normalization to *S*. *aureus* {#sec015}
------------------------------

To allow quantification of CPE spike organisms after enrichment in experiment 4, a standard inoculum of 10^7^ CFU *S*. *aureus* was added to samples after enrichment and immediately prior to DNA extraction. Detection of DNA reads from different organisms depends on several factors such as genome size, efficiency of DNA extraction, efficiency of sequencing and efficiency of bioinformatic classification. These can be combined into a single measure of relative detection efficiency (RDE) compared to *S*. *aureus*, which was established using unenriched samples in which the concentration of the spike organism and *S*. *aureus* were both known. For each CPE spike organism, the mean RDE was determined from the 2 unenriched samples in experiment 4 spiked with 5x10^7^ CFU/g CPE and 10^7^ CFU *S*. *aureus*. The following formula was used, based on the relative proportions of the known CPE and *S*. *aureus* CFU, and the relative proportions of the reads assigned to the CPE species and *S*. *aureus* by Kraken: $$\frac{Spike~organism~reads}{S.~aureus~reads} = \text{RDE~x~}\frac{Spike~CFU}{S.~aureus~CFU}$$ The calculated RDE was then used to estimate the number of CFUs present in samples after enrichment.

Statistical analysis {#sec016}
--------------------

All statistical analyses were performed in R, version 3.5.0. Means were compared using a Welch two sample t-test, which allows unequal variances in the two groups.

Results {#sec017}
=======

Experiment 1 ---Comparison of DNA extraction methods {#sec018}
----------------------------------------------------

Use of the QuickLyse plasmid extraction method increased the number of reads mapping to plasmid-associated beta-lactamases to a mean of 15.7 Reads per Kb per million (RPKM) (95% CI 6.2--25.1) compared to a mean of 4.4 RPKM (95% CI 2.4--6.4, t-test for difference p = 0.03) using the Fast DNA Stool kit ([S1 Fig](#pone.0222831.s001){ref-type="supplementary-material"}).

Experiment 2 --Establishing the optimal duration of enrichment culture {#sec019}
----------------------------------------------------------------------

Selective enrichment of *Enterobacteriaceae* in broth containing vancomycin and metronidazole demonstrated that they were in log-phase growth up to approximately 8 hours of incubation ([Fig 1](#pone.0222831.g001){ref-type="fig"}). Six hours was selected as the optimal incubation period, as this provided approximately 10^4^-fold enrichment while preserving the ratios of the different *E*. *coli* strains present at baseline.

![Growth of *Enterobacteriaceae* during incubation of a fecal sample.\
A single sample was incubated in broth containing vancomycin and metronidazole. Two distinct morphotypes of *E*. *coli* were present. No *K*. *pneumoniae* were isolated at 0 hours, implying presence below the limit of detection of 10^3^ CFU/g. Lines join the geometric means of 2 replicates.](pone.0222831.g001){#pone.0222831.g001}

Experiment 3 --Sequencing after selective enrichment with vancomycin and metronidazole {#sec020}
--------------------------------------------------------------------------------------

Culture-enrichment in broth containing vancomycin and metronidazole showed that at all spiking concentrations tested, the spike organism was barely detectable above endogenous *E*. *coli* present in the sample, with a mean relative abundance of *E*. *coli* of 3.5% (range 2.9--4.4%) in 16 unenriched samples, and 98.0% (range 97.2--98.6%) in 16 enriched samples ([S2 Fig](#pone.0222831.s002){ref-type="supplementary-material"}). The NDM-1 gene was scarcely measurable in any sample, being detected in just a single read in 3 enriched samples: 2 of 3 spiked at 5x10^5^ CFU/g, and 1 of 3 spiked at 5x10^4^ CFU/g, in each case corresponding to an abundance of \<1 RPKM (starred samples in [S2 Fig](#pone.0222831.s002){ref-type="supplementary-material"}).

Experiment 4 ---Sequencing after selective enrichment with vancomycin, metronidazole and cefpodoxime {#sec021}
----------------------------------------------------------------------------------------------------

As enrichment with metronidazole and vancomycin alone did not allow detection of a resistant subpopulation of *Enterobacteriaceae*, a revised protocol was developed which added cefpodoxime to suppress growth of susceptible *Enterobacteriaceae* and used the QuickLyse plasmid extraction method from experiment 1.

Using this revised protocol, CPE spikes above 5x10^5^ CFU/g led to a relative abundance of ≥90% the spike organism after enrichment, based on taxonomic classification of sequence data ([Fig 2](#pone.0222831.g002){ref-type="fig"}). At lower spiking concentrations, there was a marked difference between the spike organisms. At an initial spike of 5x10^2^ CFU/g, *K*. *pneumoniae* had a mean relative abundance of 58% compared to 3% for *E*. *cloacae*. In all unenriched samples the spike organism was present at a relative abundance of \<10%.

![Relative abundance of CPE following culture-enrichment of spiked fecal samples.\
Initial CPE spike versus measured abundance of spike organism by sequencing, with or without enrichment in broth containing cefpodoxime, vancomycin, and metronidazole. Two spike CPE (*K*. *pneumoniae* & *E*. *cloacae*) and two volunteer samples (A & B) were used. Lines join the arithmetic means of 2 replicates. Unspiked samples are shown on the y-axis.](pone.0222831.g002){#pone.0222831.g002}

As our objective was to measure the absolute, as well as relative, abundance of organisms present in samples, we estimated the abundance of spike organisms after enrichment by comparing reads assigned to the spike to those assigned to the *S*. *aureus* standard. Abundance estimation in the enriched samples showed that the number of spike organisms increased with higher initial spiking concentration even after the relative abundance had plateaued ([Fig 3](#pone.0222831.g003){ref-type="fig"}). Comparing these sequencing-based estimates to measurement by quantitative culture showed reasonable correlation at abundances below 10^9^ CFU, corresponding to initial spikes \<5x10^5^ CFU/g, with all estimates within 1 log~10~ of the culture value ([Fig 4](#pone.0222831.g004){ref-type="fig"}). However, at higher abundances, where the number of spike CFU in the sample was more than 300-fold higher than the number of *S*. *aureus* CFU, the number of spike organisms estimated by sequencing consistently underestimated culture values.

![Estimated number of CPE organisms following culture-enrichment of spiked fecal samples.\
Initial CPE spike versus final number of CPE spike organisms estimated from sequence data by normalization to *S*. *aureus*. With and without enrichment in broth containing cefpodoxime, vancomycin, and metronidazole. Two spike organisms (*K*. *pneumoniae* & *E*. *cloacae*) and two volunteer samples (A & B) were used. Lines join the geometric means of 2 replicates.](pone.0222831.g003){#pone.0222831.g003}

![Comparison of CPE organisms estimated by sequencing and culture.\
Number of spike organisms estimated by sequencing compared to measurement by culture. Samples enriched in broth containing cefpodoxime, vancomycin, and metronidazole. Two spike organisms (*K*. *pneumoniae* & *E*. *cloacae*) and two volunteer samples (A & B) used. Points represent the geometric means of 2 replicates, shaded areas are within 0.5 and 1.0 log~10~ of the line of identity.](pone.0222831.g004){#pone.0222831.g004}

Detection of the carbapenemase genes differed markedly between the two spike organisms (solid lines in [Fig 5](#pone.0222831.g005){ref-type="fig"}). The KPC-2 gene present in *E*. *cloacae* was detected at a mean 8 RPKM (range 4--12) at the lowest spike of 5x10^2^ CFU/g, implying a limit of detection of approximately 50 CFU/g per million reads. In contrast, the NDM-1 gene present on *K*. *pneumoniae* was detected at around 100 RPKM even at the lowest initial spike and hardly changed with higher spiking concentrations, in keeping with the higher abundance of *K*. *pneumoniae* noted above. This prevented estimation of the limit of detection of NDM-1 in this context.

![Detection of genes present in CPE following culture-enrichment of spiked fecal samples.\
Initial CPE spike versus RPKM mapping to carbapenemase genes (solid lines, NDM-1 in *K*. *pneumoniae*, KPC-2 in *E*. *cloacae*) and gyrA (dashed lines). Samples enriched in broth containing cefpodoxime, vancomycin, and metronidazole. Two spike organisms (*K*. *pneumoniae* & *E*. *cloacae*) and two volunteer samples (A & B) were used. Lines join the arithmetic means of 2 replicates. Unspiked samples are shown on the y-axis.](pone.0222831.g005){#pone.0222831.g005}

At the highest spiking concentrations, the number of RPKM mapping to the carbapenemase gene was around 4 times higher in *E*. *cloacae* than *K*. *pneumoniae*, even though both organisms were present at \>90% abundance. This difference did not appear to relate to the plasmid copy number, as in sequenced isolates the carbapenemase genes are present at similar copy numbers of 1.8--1.9. To explore the possibility that this difference related to efficiency of plasmid extraction, we compared the number of reads mapping to the plasmid-associated carbapenemase to those mapping to the chromosomal *gyrA* gene (dashed lines in [Fig 5](#pone.0222831.g005){ref-type="fig"}). In *E*. *cloacae*, DNA from the 43kb KPC plasmid was extracted more efficiently than the chromosomal *gyrA* gene, leading to greater detection of KPC-2 vs gyrA. In contrast, in *K*. *pneumoniae* DNA from the 305kb NDM-1 plasmid and *gyrA* was extracted at similar efficiencies.

As well as the NDM-1 plasmid, the *K*. *pneumoniae* spike also contained DNA mapping to two small plasmids, pEC34A (3.8kb) and pRGRH1815 (7.1kb), although the structure of these in the spike organism could not be resolved with available sequence data \[[@pone.0222831.ref023]\]. This DNA was extracted at a very high efficiency in enriched samples, and the extraction efficiency relative to chromosomal DNA increased with higher spiking concentrations ([S3 Fig](#pone.0222831.s003){ref-type="supplementary-material"}). At the highest spikes this small plasmid DNA made up around a quarter of all reads, causing a relative decrease in other *K*. *pneumoniae* DNA.

Discussion {#sec022}
==========

Selective culture-enrichment of stool samples has been successfully used by Raymond et al to characterize low abundance constituents of the microbiome that would have been undetectable with standard metagenomic sequencing, albeit without any attempt at quantification \[[@pone.0222831.ref024]\]. In this study, we aimed to create a simple, quantitative assay of resistance genes in culturable organisms using a short period of selective culture followed by sequencing directly from the enriched sample. We chose culture conditions that would amplify a resistant subpopulation of *Enterobacteriaceae* of particular clinical importance, specifically those resistant to third generation cephalosporins, with the aim of bringing their resistance genes above the threshold of detection. It is important that enrichment of resistant organisms is not at the expense of quantification, so after initial experiments to define the growth of *Enterobacteriaceae* in selective broth culture we chose an incubation period of 6 hours, which was found to produce a 10^4^-fold increase without going past log-phase growth, which would have prevented estimation of the starting concentration.

Performance of the enrichment-sequencing protocol was assessed by spiking fecal samples with known concentrations of CPE. While there were minimal differences between samples from different individuals, there were large differences between the two spike organisms. Consistency between the fecal samples, and between replicates, implies that this relates to intrinsic growth characteristics of the strains used in this experiment. Our finding of such large variation in growth between different strains of *Enterobacteriaceae* precludes accurate estimation of their starting concentration unless their growth characteristics are known, undermining one of the aims of the assay. In fact, relatively small differences in growth rates could produce such differences after 6 hours. For example, if two *Enterobacteriaceae* strains had doubling times of 18 minutes and 22 minutes, then this would lead to a 12-fold difference in their abundance after 6 hours incubation. As well as intrinsic differences between bacterial strains, variation in growth rate can also be influenced by total bacterial concentration \[[@pone.0222831.ref025]\] and the fecal environment \[[@pone.0222831.ref026]\].

To estimate the absolute abundance of organisms in the sample using sequence data it is necessary to use some form of standard. Although our use of a *S*. *aureus* standard allowed reasonable estimation of the number of post-enrichment spike organisms at low abundances, it correlated poorly with quantitative culture at higher abundances ([Fig 4](#pone.0222831.g004){ref-type="fig"}). This is likely to be related to small amounts of contaminating DNA assigned to the standard, as even in negative controls with no fecal sample a small number of reads were assigned to *S*. *aureus*. This could possibly be improved by using an alternative standard with less homology to any possible contaminants or organisms present in the sample.

Another novel aspect of this protocol was the use of plasmid DNA extraction, which increased the detection of plasmid-mediated resistance genes in *Enterobacteriaceae* in preliminary spiking experiments. To our knowledge this is the first study to compare plasmid DNA extraction to standard DNA extraction for resistome assessment in humans. One study assessing AMR genes in environmental metagenomes found that plasmid extraction could increase detection of some resistance genes 37 fold \[[@pone.0222831.ref027]\], but in our study the effect on the genes of interest was much more modest, with increases of only 3--4 fold. More problematically, plasmid DNA extraction produced unwanted artefacts because of differential extraction efficiency depending on plasmid size. This was noticeable when comparing the 305kb and 43kb carbapenemase containing plasmids, but was much more marked in relation to reads mapping to small 4-7kb plasmids, which were extracted at extremely high efficiency compared to other DNA.

This study has several limitations. It was only possible to assess a limited number of conditions, and the quantitative findings of this study may have been different if using different spike organisms, culture conditions or plasmid extraction methods, although it seems unlikely that the qualitative conclusions would differ. The use of a plasmid extraction kit in some experiments means that measured bacterial abundances will be biased towards organisms that are extracted more efficiently with this method, but this effect should be consistent between conditions in the same experiment. Finally, although we detected DNA mapping to known small plasmids in samples spiked with *K*. *pneumoniae*, we are unable to resolve the exact plasmid structures or sizes with available sequencing data.

Given the difficulties with the methods tested here, alternative ways of quantifying scarce AMR genes are needed. A promising alternative is to use target capture, in which a custom library of nucleic acid probes is used to enrich resistance genes directly from a standard metagenomic DNA extract. Using such a method, Noyes et al \[[@pone.0222831.ref028]\] were able to increase the proportion of sequenced reads mapping to resistance genes over 100-fold, and detected important resistance mechanisms, such as KPC, that were missed with standard metagenomic sequencing. Their workflow also incorporated unique molecular indices to improve the reliability of quantification. Using a different target capture system, Lanza et al increased the proportion of reads mapping to resistance genes 279-fold \[[@pone.0222831.ref010]\]. Both studies compared target capture and sequencing to standard metagenomic sequencing, but neither were tested on samples with a known concentration of antimicrobial resistant organism or on negative controls. Our study demonstrates the need to validate methods in well characterized conditions before they can reliably be used to make quantitative comparisons.

Conclusions {#sec023}
===========

Our study has assessed novel approaches to lowering the limit of detection of AMR genes in *Enterobacteriaceae* in a sequencing-based assay of the intestinal resistome. By comparing different strains of *Enterobacteriaceae* we have demonstrated the difficulty of using culture enrichment whilst maintaining quantification. Assessing the differential effect of plasmid DNA extraction by plasmid size has highlighted the artefacts that make it inappropriate for use in a resistome assay requiring accurate quantification. Further attempts at quantitative resistome assessment must either use different methods to amplify scarce AMR genes, or accept the likelihood of missing genes in low abundance organisms, which may include important pathogens such as *Enterobacteriaceae*.

Supporting information {#sec024}
======================

###### Effect of plasmid extraction on detection of beta-lactamase genes.

Reads mapping to plasmid-associated beta-lactamases in DNA extracted from fecal samples spiked with 10^8^ CPE/g. Two DNA extraction methods were compared using one of two spike CPE (*K*. *pneumoniae* & *E*. *cloacae*) and one of two volunteer samples (A & B). QuickLyse extractions were performed in duplicate.

(TIF)

###### 

Click here for additional data file.

###### *E*. *coli* abundance following culture-enrichment of spiked feces.

Aliquots of a single fecal sample spiked with NDM-1 *E*. *coli*, with or without 6 hours of enrichment in broth containing vancomycin and metronidazole. Note that the sample contained endogenous non-CPE *E*. *coli*. Stars indicate the three samples in which a single DNA read mapped to the NDM-1 gene, with no reads mapping to the gene in any other samples. Lines join the arithmetic means of 3 replicates. Unspiked samples are shown on the y-axis.

(TIF)

###### 

Click here for additional data file.

###### Detection of plasmid markers present in CPE following culture-enrichment of spiked fecal samples.

Initial *K*. *pneumoniae* spike versus ratio of plasmid-marker to chromosomal gyrA reads. Samples enriched in broth containing cefpodoxime, vancomycin, and metronidazole. Two volunteer samples (A & B) were used. Lines join the geometric means of 2 replicates.

(TIF)

###### 

Click here for additional data file.

Carbapenemase-producing *Enterobacteriaceae* strains provided by Nicole Stoesser. Carbapenemase copy estimation performed by Anna Sheppard.

10.1371/journal.pone.0222831.r001
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2\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was suitably informed.

3\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: No

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: No

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Metagenomic analysis of antimicrobial resistance (AMR) genes in stool is an area of great interest and utility. Yet, it faces the problem of low detection of organisms present in low abundance (e.g., the Enterobacteriaceae). The authors propose a unique approach involving the selective enrichment of Enterobacteriaceae members before metagenomic analysis to increase detection efficiency. The also compare efficiency of two DNA extraction methods. Although, the results indicate variable success, the results should serve as a stepping stone for future investigations and improvements.

The article does satisfy the criteria listed for publication in PLOS ONE. The study presents the results of primary scientific research that has not been published elsewhere. The experiments are well conceived and well described. The rational for each experiment is adequately discussed. The results are appropriately presented. The conclusions are strongly based on data presented. Statistical analyses are appropriate and satisfactory. The writing style is very good and easy to follow. All ethical considerations are satisfactory. The article adheres to appropriate reporting guidelines and community standards for data availability.

Two minor typos were encountered

Line 172:

Sentence should not begin with a number i.e., "50μl"

Line 544:

"Effect of plasmid extraction of detection" should be "on detection"

Reviewer \#2: This is a study focused on testing different methods for enrichment of Enterobacteriaceae for detection of carbapenemase gene and gyrA gene. The goal was to use an in vitro approach of spiking samples with the goal of developing new methodological areas that could be used as a focus for approaches using shotgun sequencing of samples focusing on the resistome (all antimicrobial resistance genes). This is an important area of research given current limitation of sequencing methods for detection of resistance genes in populations that although present in lower abundance, are of great relevance clinically. The methods seem adequate for the goals proposed, but lack enough information that would allow repetition of this approach. Given the strong methodological character of this study, this is of grave importance and need to be addressed. The title of the manuscript is misleading given the focus of the study, and should be re-phrased. The study does not present any statistical approaches, which should be added (at least what tools were used to compared descriptive results). The discussion should include more information about other studies focused on enrichment of samples for resistome analysis, and how outcomes of current method compare (e.g. "Enrichment allows identification of diverse, rare elements in metagenomic resistome-virulome sequencing . Noyes et al, 2017" - - as a disclosure, the reviewer is not involved with the research group from this manuscript)

Title -- the title of this study is misleading given that it focused on specific bacteria (select Enterobacteriaceae) and specific resistance genes. I strongly suggest the title accurately reflect the conditions that were tested in the study.

Introduction

Line 54 -- Could you further clarify what you mean with "binary measures of colonization". It was not very clear to me what specifically you meant in relation to clonal dissemination of resistance.

Line 56-57 -- I suggest adding that you mean "resistant" to antimicrobial drugs.

Line 62-64 -- You talk about PCR here but make a reference to a microarray approach (reference number 7). I would suggest differentiating PCR (and maybe talking about qPCR instead) and microarray approach for detecting AMR genes.

Line 73 -- I would suggest including Salmonella in the list of important enterobacteriaceae.

Line 86-89 -- Having a section of the conclusion in the introduction seems atypical. I would suggest including what your hypothesis for the study was instead and presenting the conclusion of the study in the conclusion section.

Method

Line 100 -- describe the methods used to label samples as ESBL negative. Culture one or two E coli isolates? Was a phenotypic approach used? Also please provide reference.

Line 126 -- How was the 5 MacFarland suspension measured?

Line 128 -- What nutrient broth was used?

Line 133- It is not clear what you meant "to allow quantification after sequencing" S. aureus was added to samples.

Line 139- Where was this approach based on? Any references for using this approach (e.g. specific antibiotics used, time of growth (why 8 hours?))? How would you compensate for difference concentration of bacteria affecting higher bacteria growth, given that bacteria have an exponential growth (not a linear growth)?

Line 146- Why were two different DNA extraction kits used, and why different enrichments used (one for each type of DNA extraction kit)?

Line 182- Although you mention different sources you used to annotate the dataset (metagenome, gyrA, plasmids), I did not see in this section what database you used to characterize resistance genes in the samples (e.g. beta-lactam resistance genes).

Line 196 -- I understand the goal of the RDE approach, but the formula is not clear to me, and more information on what each variable means may resolve some questions. Also, where are the "4 unreached samples" coming from?

Statistical analysis

\- Where is the statistical analysis section of this manuscript?

Results

Line 213-225- Part of this should be in the introduction and methods, not in the results. I suggest you be direct when presenting the results.

Line 230-241 -- This should be in the methods. It is very confusing reading the enrichment section in the material in methods in part because this information is not present in that section.

Line 258 -- Was this difference between unenriched and enriched significantly different? Where are the statistical methods used for this study?

Line 280 -- What do you mean with "relative abundance of the spike organism of \>= 90%? Relative abundance could indicate what percent of the bacteria are present in relation to the total population. Here do you mean that, or what % of the total bacteria amount spiked in the sample you are retrieving?

Figure 2 -- Enrichment does seems to affect bacteria growth in a matter that is not linear as a greater amount of initial bacteria is spiked in the sample, as expected due to exponential growth of bacteria. How do you account for this effect on the quantification of resistance genes between samples with different initial amount of a bacteria of interest? ( in other words, how to you account for the inflation in the results caused by enrichment towards samples with higher initial AMR bacteria concentration)

Line 294 -- By using Staphylococcus after enrichment, you accounted for the impact of all methods starting at and after DNA extraction on output between two or more different samples. However you did not account for the potential for unequal growth of a specific AMR bacteria caused by the enrichment process.

Line 303 -- "outnumbered" -- correct grammar error

Figure 5 -- The legend of figure 5 does not seem to make sense ( I was able to understand what was happening based on the figure description ( the solid and dashed lines)

Discussion

Line 360-372 -- None of the findings of the study are discussed in this paragraph and seems a repetition of content from the introduction. I suggest either inserting and linking finding of the study to the content provided here or removing this sentence from the manuscript.

Line 380-382 -- Provide more information about what incubation period was selected, and why it was relevant, and how does it compare to other approaches available in literature

Line 392-394 -- I think this is relevant information, but it is not clearly outlined here. I suggest better explaining what you meant here. One option is to give an example for a specific bacteria used in the study.

Line 401 - please link this information to the figure where this data is presented.

Conclusion

This study did not look at all AMR genes, but was limited to a small select number of genes. I would suggest adjusting the conclusion of the study to reflect the specific conditions that were tested, which are still very relevant.

Reviewer \#3: The authors of this article have developed a very interesting topic of research namely metagenomic sequencing of fecal DNA to characterise an individual's intestinal resistome. Metagenomics is a method that, instead of sequencing individual genomes, collectively analyzes all DNA isolated from a specific sample, representing all microorganisms. It can provides information about which organisms are present in the sample and what metabolic processes are possible in the community. The Authors of this study aimed to develop a hybrid protocol to improve detection of resistance genes in Enterobacteriaceae by using a short period of culture enrichment prior to sequencing of DNA extracted directly from the enriched sample. They chose culture conditions that would amplify a resistant subpopulation of Enterobacteriaceae of particular clinical importance, specifically those resistant to third generation cephalosporins, with the aim of bringing their resistance genes above the threshold of detection. Performance of the enrichment-sequencing protocol was assessed by spiking fecal samples with known concentrations of CPE. Their finding of such large variation in growth between different strains of Enterobacteriaceae precludes accurate estimation of their starting concentration unless their growth characteristics are known, undermining one of the aims of the assay. Another aspect of this protocol was the use of plasmid DNA extraction, which increased the detection of plasmid-mediated resistance in Enterobacteriaceae in preliminary spiking experiments. It was problematically that, plasmid DNA extraction produced unwanted artefacts because of differential extraction efficiency depending on plasmid size. In the conclusions, the authors stated that, alternative ways of quantifying scarce AMR genes are needed. However, their study demonstrates the need for any method to be validated in a range of well characterized conditions before it can reliably be used to make quantitative comparisons.

In the assessment of this manuscript I state that the concept of the presented research was well planned. In the \"Abstract\" section, the general assumption of the research undertaken is clearly presented. However, little information was given about the methodology used. Perhaps this is due to the limitations of the text volume in this section. The introduction is short, but it introduces the reader to the research topic in a sufficient way. The \"Material and Methods\" and \"Results\" sections present the subsequent stages of the research and the results in a detailed manner. In the \"Discussion\" section, the authors should compare the results of their own research with the results of other authors.

In summary, I find that the article is written in a way that meets the criteria of PLOS ONE. The applied research methods are well-chosen. In connection with this assessment, I recommend this manuscript for publication in the Journal PLOS ONE.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Samer Swedan

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 0

20 Aug 2019

Response to reviewers comments (\*\*\*identical to uploaded Response to Reviewers\*\*\*)

We apologise that one correction was required to the data cited in line 352 of the revised manuscript. 'E. cloacae was detected at a mean 12 RPKM (range 5-17)' has been corrected to 'E. cloacae was detected at a mean 8 RPKM (range 4-12)'. The incorrect numbers in the text were from a previous method of mapping reads to AMR genes. The mapping method described in the methods section had otherwise been used throughout, including in figures. This correction does not affect the interpretation or discussion.

Journal Requirements:

1\. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Headings reformatted

2\. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was suitably informed.

Informed consent added (new line 147-148)

3\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Reviewer \#1: Metagenomic analysis of antimicrobial resistance (AMR) genes in stool is an area of great interest and utility. Yet, it faces the problem of low detection of organisms present in low abundance (e.g., the Enterobacteriaceae). The authors propose a unique approach involving the selective enrichment of Enterobacteriaceae members before metagenomic analysis to increase detection efficiency. The also compare efficiency of two DNA extraction methods. Although, the results indicate variable success, the results should serve as a stepping stone for future investigations and improvements.

The article does satisfy the criteria listed for publication in PLOS ONE. The study presents the results of primary scientific research that has not been published elsewhere. The experiments are well conceived and well described. The rational for each experiment is adequately discussed. The results are appropriately presented. The conclusions are strongly based on data presented. Statistical analyses are appropriate and satisfactory. The writing style is very good and easy to follow. All ethical considerations are satisfactory. The article adheres to appropriate reporting guidelines and community standards for data availability.

Line 172:

Sentence should not begin with a number i.e., "50μl"

Corrected (new line 221)

Line 544:

"Effect of plasmid extraction of detection" should be "on detection"

Corrected (new line 585)

Reviewer \#2: This is a study focused on testing different methods for enrichment of Enterobacteriaceae for detection of carbapenemase gene and gyrA gene. The goal was to use an in vitro approach of spiking samples with the goal of developing new methodological areas that could be used as a focus for approaches using shotgun sequencing of samples focusing on the resistome (all antimicrobial resistance genes). This is an important area of research given current limitation of sequencing methods for detection of resistance genes in populations that although present in lower abundance, are of great relevance clinically. The methods seem adequate for the goals proposed, but lack enough information that would allow repetition of this approach. Given the strong methodological character of this study, this is of grave importance and need to be addressed.

Methods have been expanded, as outlined below

The title of the manuscript is misleading given the focus of the study, and should be re-phrased.

Amended, as outlined below

The study does not present any statistical approaches, which should be added (at least what tools were used to compared descriptive results).

Added, as outlined below

The discussion should include more information about other studies focused on enrichment of samples for resistome analysis, and how outcomes of current method compare (e.g. "Enrichment allows identification of diverse, rare elements in metagenomic resistome-virulome sequencing . Noyes et al, 2017" - - as a disclosure, the reviewer is not involved with the research group from this manuscript)

We appreciate being made aware of the study by Noyes 2017. We had mentioned another study (Lanza 2018) that also used target capture, but have now expanded this part of the discussion and refer to both studies. We also now refer to Raymond 2019, which used culture-enrichment and sequencing for the characterisation of fecal resistomes, but which was published after the original manuscript was drafted. New lines 389-392 & 454-466

Title -- the title of this study is misleading given that it focused on specific bacteria (select Enterobacteriaceae) and specific resistance genes. I strongly suggest the title accurately reflect the conditions that were tested in the study.

The original title reflects the fact that this approach could apply to detection of resistance genes in any selectively culturable organisms, with third generation cephalosporin resistant Enterobacteriaceae chosen as a model. However, we see how this could be misinterpreted, and have amended the title to "Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae"

Introduction

Line 54 -- Could you further clarify what you mean with "binary measures of colonization". It was not very clear to me what specifically you meant in relation to clonal dissemination of resistance.

We have clarified that we meant classifying an individual as colonised or not with a resistant organism, versus measuring its abundance. New line 52

Line 56-57 -- I suggest adding that you mean "resistant" to antimicrobial drugs.

Added. New lines 54-55

Line 62-64 -- You talk about PCR here but make a reference to a microarray approach (reference number 7). I would suggest differentiating PCR (and maybe talking about qPCR instead) and microarray approach for detecting AMR genes.

Although the paper originally cited used PCR to detect AMR genes in feces, its main focus was validation of a microarray. We have cited two more relevant recent papers instead to make the original point about PCR. New lines 61-63

Line 73 -- I would suggest including Salmonella in the list of important enterobacteriaceae.

Added. New line 72

Line 86-89 -- Having a section of the conclusion in the introduction seems atypical. I would suggest including what your hypothesis for the study was instead and presenting the conclusion of the study in the conclusion section.

This was done to follow the PLOS ONE author instructions regarding the introduction ('Conclude with a brief statement of the overall aim of the work and a comment about whether that aim was achieved'). We have therefore not changed it.

Method

Line 100 -- describe the methods used to label samples as ESBL negative. Culture one or two E coli isolates? Was a phenotypic approach used? Also please provide reference.

Details added. New lines 153-156

Line 126 -- How was the 5 MacFarland suspension measured?

Make of nephelometer added. New lines 183-184.

Line 128 -- What nutrient broth was used?

Details added. New line 183.

Line 133- It is not clear what you meant "to allow quantification after sequencing" S. aureus was added to samples.

We have clarified that this was to allow estimation of the number of CPE organisms in post-enrichment samples. New lines 138-141.

Line 139- Where was this approach based on? Any references for using this approach (e.g. specific antibiotics used, time of growth (why 8 hours?))? How would you compensate for difference concentration of bacteria affecting higher bacteria growth, given that bacteria have an exponential growth (not a linear growth)?

The justification for the antibiotics used is given in lines 235-237 & 268-269 of the original manuscript (new lines 112-115 & 303-304). Selective culture in Mueller Hinton broth is commonly used in microbiological practice, and we consider that the conditions chosen are justified by the data presented in Figure 1.

Exponential growth does not preclude quantification of the initial organism concentration, provided the doubling times are reasonably well known. This is demonstrated by the growth curves of the two different strains of E. coli in Figure 1, where during the exponential phase growth is linear on a log scale with the same slope. In fact, doubling times were different enough between different species of Enterobacteriaceae to cause a problem with quantification in the subsequent experiment, and this finding is emphasised in the discussion.

Line 146- Why were two different DNA extraction kits used, and why different enrichments used (one for each type of DNA extraction kit)?

Lines 255-262 of the original manuscript (new lines 302-305) describe why the failure of the initial approach of selective culture with vancomycin and metronidazole led to a revised protocol incorporating both more selective culture conditions (by adding cefpodoxime) and the use of an alternative extraction protocol (which we had shown in new lines 270-273 to have superior detection of plasmid-associated beta-lactamases).

We do not make any direct comparisons between results using the first and second enrichment protocols, so changing two aspects of the protocol simultaneously does not cause a problem in interpretation. As this point was not raised by other reviewers we have not made specific changes in response to this comment.

Line 182- Although you mention different sources you used to annotate the dataset (metagenome, gyrA, plasmids), I did not see in this section what database you used to characterize resistance genes in the samples (e.g. beta-lactam resistance genes).

We have clarified that we used genes from the assembled reference genomes of the spike organisms in the bioinformatics section of the methods. New lines 237-238.

Line 196 -- I understand the goal of the RDE approach, but the formula is not clear to me, and more information on what each variable means may resolve some questions. Also, where are the "4 unreached samples" coming from?

We have clarified the different components of the formula, and clarified that the unenriched \[not unreached\] samples shown in Figure 3 were those that this relative detection efficiency (RDE) is calculated on. New lines 253-261.

Statistical analysis

\- Where is the statistical analysis section of this manuscript?

The only statistical analysis was t-tests with unequal variance, which is now added to methods section (previously we had just referred to the test statistic when presenting the test results). New lines 263-265.

Line 213-225- Part of this should be in the introduction and methods, not in the results. I suggest you be direct when presenting the results.

The results were previously written to be understandable without reference to the methods. We agree that having the rationale for experiments in the methods is more in keeping with typical PLOS ONE style, and so we have restructured the methods and results sections. See new Experiment 1-4 sections of methods, new lines 91 -143.

Line 230-241 -- This should be in the methods. It is very confusing reading the enrichment section in the material in methods in part because this information is not present in that section.

We have re-ordered the presentation as suggested

Line 258 -- Was this difference between unenriched and enriched significantly different?

The difference is formally statistically significant (p\<10-16¬) but we do not feel this is particularly helpful as we are not testing the hypothesis that enrichment increases the number of E. coli (this is known); instead we have added the ranges of mean relative abundance (which are completely non-overlapping, obviating the need for statistical testing) to the text instead. New lines 294-295.

Where are the statistical methods used for this study?

Added to the main Methods, as described above.

Line 280 -- What do you mean with "relative abundance of the spike organism of \>= 90%? Relative abundance could indicate what percent of the bacteria are present in relation to the total population. Here do you mean that, or what % of the total bacteria amount spiked in the sample you are retrieving?

We have clarified that this meant \>90% relative abundance, as determined taxonomic classification of sequence data. New lines 308-309.

Figure 2 -- Enrichment does seems to affect bacteria growth in a matter that is not linear as a greater amount of initial bacteria is spiked in the sample, as expected due to exponential growth of bacteria. How do you account for this effect on the quantification of resistance genes between samples with different initial amount of a bacteria of interest? ( in other words, how to you account for the inflation in the results caused by enrichment towards samples with higher initial AMR bacteria concentration)

We agree that these comparisons are not straightforward. First, exponential growth should be linear on a log scale. Figure 2 shows relative abundance, as this is the output from sequencing, but one would not expect this to be linearly related to the number of organisms present in the sample (e.g. if the number of organisms at 80% abundance doubled its new relative abundance would be 89%). This is why we used a standard spike of S. aureus to estimate the absolute number of organisms, and explain this rationale in the methods and results. That this provides more linearity is shown in Figure 3, but, as we show by comparing these estimates to culture in Figure 4, even this does not work adequately at high CPE concentrations. We consider reasons for this in the discussion in new lines 419-427. We have clarified this distinction between relative and absolute abundance in the results, new lines 307-313.

Line 294 -- By using Staphylococcus after enrichment, you accounted for the impact of all methods starting at and after DNA extraction on output between two or more different samples. However you did not account for the potential for unequal growth of a specific AMR bacteria caused by the enrichment process.

We agree; for this method to quantify the starting concentration accurately growth must be sufficiently similar between Enterobacteriaceae. That we found this not to be the case is acknowledged in the abstract & discussion. New lines 34-36 & 404-417.

Line 303 -- "outnumbered" -- correct grammar error

Clarified. New lines 331-332.

Figure 5 -- The legend of figure 5 does not seem to make sense ( I was able to understand what was happening based on the figure description ( the solid and dashed lines)

Clarified. New lines 359-365.

Discussion

Line 360-372 -- None of the findings of the study are discussed in this paragraph and seems a repetition of content from the introduction. I suggest either inserting and linking finding of the study to the content provided here or removing this sentence from the manuscript.

As suggested, we have removed this paragraph re-iterating points made in the background, making the discussion more concise.

Line 380-382 -- Provide more information about what incubation period was selected, and why it was relevant, and how does it compare to other approaches available in literature

Added information about how the incubation period was chosen as suggested. New lines 400-402. Comparison with other approaches is covered later in the Discussion.

Line 392-394 -- I think this is relevant information, but it is not clearly outlined here. I suggest better explaining what you meant here. One option is to give an example for a specific bacteria used in the study.

We have clarified this point with reference to bacteria from the study. New lines 413-415.

Line 401 - please link this information to the figure where this data is presented.

Added. New line 423.

Conclusion

This study did not look at all AMR genes, but was limited to a small select number of genes. I would suggest adjusting the conclusion of the study to reflect the specific conditions that were tested, which are still very relevant.

We used these specific genes as positive controls in our experimental design -- without knowing what genes are in a sample, it would not be possible to conduct the experiments we performed. We cannot see any reason why our findings with regard to differential doubling times and plasmid extraction would not be generalizable to other AMR genes in Enterobacteriaceae. We therefore consider that the conclusions as presented are reasonable and do not go beyond the data from this study - they only refer to AMR genes in Enterobacteriaceae, and they are applicable to selective enrichment using antibiotics other than the ones tested in the study. We note that neither of the other two reviewers had concerns about this.

Reviewer \#3: The authors of this article have developed a very interesting topic of research namely metagenomic sequencing of fecal DNA to characterise an individual's intestinal resistome. Metagenomics is a method that, instead of sequencing individual genomes, collectively analyzes all DNA isolated from a specific sample, representing all microorganisms. It can provides information about which organisms are present in the sample and what metabolic processes are possible in the community. The Authors of this study aimed to develop a hybrid protocol to improve detection of resistance genes in Enterobacteriaceae by using a short period of culture enrichment prior to sequencing of DNA extracted directly from the enriched sample. They chose culture conditions that would amplify a resistant subpopulation of Enterobacteriaceae of particular clinical importance, specifically those resistant to third generation cephalosporins, with the aim of bringing their resistance genes above the threshold of detection. Performance of the enrichment-sequencing protocol was assessed by spiking fecal samples with known concentrations of CPE. Their finding of such large variation in growth between different strains of Enterobacteriaceae precludes accurate estimation of their starting concentration unless their growth characteristics are known, undermining one of the aims of the assay. Another aspect of this protocol was the use of plasmid DNA extraction, which increased the detection of plasmid-mediated resistance in Enterobacteriaceae in preliminary spiking experiments. It was problematically that, plasmid DNA extraction produced unwanted artefacts because of differential extraction efficiency depending on plasmid size. In the conclusions, the authors stated that, alternative ways of quantifying scarce AMR genes are needed. However, their study demonstrates the need for any method to be validated in a range of well characterized conditions before it can reliably be used to make quantitative comparisons.

In the assessment of this manuscript I state that the concept of the presented research was well planned. In the \"Abstract\" section, the general assumption of the research undertaken is clearly presented. However, little information was given about the methodology used. Perhaps this is due to the limitations of the text volume in this section. The introduction is short, but it introduces the reader to the research topic in a sufficient way. The \"Material and Methods\" and \"Results\" sections present the subsequent stages of the research and the results in a detailed manner. In the \"Discussion\" section, the authors should compare the results of their own research with the results of other authors.

We have expanded the discussion to include more reference to other studies, as outlined above

In summary, I find that the article is written in a way that meets the criteria of PLOS ONE. The applied research methods are well-chosen. In connection with this assessment, I recommend this manuscript for publication in the Journal PLOS ONE.
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Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae
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